Trial results prompt scientists to call for greater use of stenting in left main artery
This article was originally published in Clinica
Using stents to treat patients with left main coronary artery disease is safe and effective in the long term, a study has found. The SYNTAX-LE MANS substudy also concluded that drug-eluting stents (DESs) were a better choice than bare-metal stents (BMSs). The LE MANS registry enrolled 252 patients with unprotected left main coronary artery disease (ULMCA). In total, BMSs were used in 158 patients and DESs in 94 (37.3%). Within the DES group, paclitaxel-eluting stents were used in 60 (63.8%) patients, whereas limus analogue-eluting stents were used in 34 (36.2%) patients.